These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 31465283)

  • 21. Careful patient selection may improve response rates to infliximab in inflammatory bowel disease.
    Pearce CB; Lawrance IC
    J Gastroenterol Hepatol; 2007 Oct; 22(10):1671-7. PubMed ID: 17845695
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surgical management of complicated and medically refractory inflammatory bowel disease during pregnancy.
    Killeen S; Gunn J; Hartley J
    Colorectal Dis; 2017 Feb; 19(2):123-138. PubMed ID: 27317641
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of Biological Therapy Before Elective Inflammatory Bowel Disease Surgeries.
    Hansen TM; Targownik LE; Karimuddin A; Leung Y
    Inflamm Bowel Dis; 2019 Sep; 25(10):1613-1620. PubMed ID: 30794289
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Advances in biologic therapy for inflammatory bowel disease].
    Sostegni R; Pera A; Daperno M; Rocca R
    Recenti Prog Med; 2008 Jan; 99(1):10-8. PubMed ID: 18389866
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The use of sirolimus (rapamycin) in the management of refractory inflammatory bowel disease in children.
    Mutalib M; Borrelli O; Blackstock S; Kiparissi F; Elawad M; Shah N; Lindley K
    J Crohns Colitis; 2014 Dec; 8(12):1730-4. PubMed ID: 25240477
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Medical therapy of inflammatory bowel disease for the 21st century.
    Robinson M
    Eur J Surg Suppl; 1998; (582):90-8. PubMed ID: 10029372
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hospital Admissions, Biological Therapy, and Surgery in Familial and Sporadic Cases of Inflammatory Bowel Disease: A Population-Based Cohort Study 1977-2011.
    Trier Moller F; Andersen V; Andersson M; Jess T
    Inflamm Bowel Dis; 2015 Dec; 21(12):2825-32. PubMed ID: 26288000
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biologic therapy in the management of extraintestinal manifestations of inflammatory bowel disease.
    Barrie A; Regueiro M
    Inflamm Bowel Dis; 2007 Nov; 13(11):1424-9. PubMed ID: 17567879
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety of biologic therapy.
    Blonski W; Lichtenstein GR
    Inflamm Bowel Dis; 2007 Jun; 13(6):769-96. PubMed ID: 17304581
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Post-operative complications in elderly onset inflammatory bowel disease: a population-based study.
    Sacleux SC; Sarter H; Fumery M; Charpentier C; Guillon-Dellac N; Coevoet H; Pariente B; Peyrin-Biroulet L; Gower-Rousseau C; Savoye G;
    Aliment Pharmacol Ther; 2018 Jun; 47(12):1652-1660. PubMed ID: 29737553
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inflammatory bowel disease surgery in the biologic era.
    Ferrari L; Krane MK; Fichera A
    World J Gastrointest Surg; 2016 May; 8(5):363-70. PubMed ID: 27231514
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increasing incidences of inflammatory bowel disease and decreasing surgery rates in Copenhagen City and County, 2003-2005: a population-based study from the Danish Crohn colitis database.
    Vind I; Riis L; Jess T; Knudsen E; Pedersen N; Elkjaer M; Bak Andersen I; Wewer V; Nørregaard P; Moesgaard F; Bendtsen F; Munkholm P;
    Am J Gastroenterol; 2006 Jun; 101(6):1274-82. PubMed ID: 16771949
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inflammatory bowel disease in the United States from 1998 to 2005: has infliximab affected surgical rates?
    Cannom RR; Kaiser AM; Ault GT; Beart RW; Etzioni DA
    Am Surg; 2009 Oct; 75(10):976-80. PubMed ID: 19886148
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk of surgery for inflammatory bowel diseases has decreased over time: a systematic review and meta-analysis of population-based studies.
    Frolkis AD; Dykeman J; Negrón ME; Debruyn J; Jette N; Fiest KM; Frolkis T; Barkema HW; Rioux KP; Panaccione R; Ghosh S; Wiebe S; Kaplan GG
    Gastroenterology; 2013 Nov; 145(5):996-1006. PubMed ID: 23896172
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of the combination of biologics and/or small molecules in the treatment of patients with inflammatory bowel disease.
    Balderramo D
    World J Gastroenterol; 2022 Dec; 28(47):6743-6751. PubMed ID: 36620336
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inflammatory bowel disease: current therapeutic options.
    Domènech E
    Digestion; 2006; 73 Suppl 1():67-76. PubMed ID: 16498254
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incidence and Clinical Outcomes of Inflammatory Bowel Disease in South Korea, 2011-2014: A Nationwide Population-Based Study.
    Jung YS; Han M; Kim WH; Park S; Cheon JH
    Dig Dis Sci; 2017 Aug; 62(8):2102-2112. PubMed ID: 28593437
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Disease course and surgery rates in inflammatory bowel disease: a population-based, 7-year follow-up study in the era of immunomodulating therapy.
    Vester-Andersen MK; Prosberg MV; Jess T; Andersson M; Bengtsson BG; Blixt T; Munkholm P; Bendtsen F; Vind I
    Am J Gastroenterol; 2014 May; 109(5):705-14. PubMed ID: 24642581
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The burden of surgery and postoperative complications in children with inflammatory bowel disease.
    Fehmel E; Teague WJ; Simpson D; McLeod E; Hutson JM; Rosenbaum J; Oliver M; Alex G; King SK
    J Pediatr Surg; 2018 Dec; 53(12):2440-2443. PubMed ID: 30244938
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of Combination Antibiotic Therapy for Refractory Pediatric Inflammatory Bowel Disease.
    Breton J; Kastl A; Hoffmann N; Rogers R; Grossman AB; Mamula P; Kelsen JR; Baldassano RN; Albenberg L
    Inflamm Bowel Dis; 2019 Aug; 25(9):1586-1593. PubMed ID: 30715364
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.